- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
132 CHAPTER 4 Incontinence
Incontinence in the elderly patient
Prevalence
UI increases markedly with advancing age, affecting 10–20% of women and 7–10% of men >65 years who are living at home. These figures escalate if older people are institutionalized, as follows: residential home, 25%; nursing home, 40%; long-stay hospital ward, 50–70%.
Functional incontinence is often associated with factors outside of the urinary tract, such as permanent immobility, cognitive impairment, and environmental changes.
Transient causes of UI (“DIAPPERS”)
•Dementia/delirium
•Infection
•Atrophic vaginitis or urethritis
•Pharmaceuticals (opiates and calcium antagonists cause urinary retention and constipation; anticholinergics cause increased PVR and retention;
•Psychological problems—depression; neurosis; anxiety
•Excess fluid input or output (diuretics; CHF; nocturnal polyuria)
•Restricted mobility
•Stool impaction (constipation)
Management
Simple measures such as timed voids or laxative use may be helpful and should be attempted initially. Biofeedback and behavioral methods are appropriate only if cognition is intact.
Treat any vaginitis (0.01% estriol cream topically) in postmenopausal females.
Absorbent appliances include bed pads and body-worn pad products (pull-up adult diapers); body-worn external urine collection devices (condom catheter) or compression devices (Cunningham clamp) may be helpful for severe leakage in males.
Indwelling catheters are initially preferable when UI is due to obstruction or no alternative intervention is suitable. Suprapubic tube placement is preferable to long-term indwelling urethral catheterization, which is often associated with pressure necrosis and/or erosion of the urethra.
Chapter 5 |
133 |
|
|
Infections and inflammatory conditions
Urinary tract infection: definitions, incidence, and investigations 134
Urinary tract infection: microbiology 138 Lower urinary tract infection 140 Recurrent urinary tract infection 142 Urinary tract infection: treatment 146 Acute pyelonephritis 148
Pyonephrosis and perinephric abscess 150 Other forms of pyelonephritis 152 Chronic pyelonephritis 154
Septicemia and urosepsis 156 Fournier gangrene 160 Epididymitis and orchitis 162 Periurethral abscess 164
Prostatitis: epidemiology and classification 166 Prostatitis: presentation, evaluation, and treatment 168 Other prostate infections 170
Interstitial cystitis 172 Tuberculosis 176 Parasitic infections 178
HIV in urological surgery 180
Inflammatory and other disorders of the penis 182
134 CHAPTER 5 Infections and inflammatory conditions
Urinary tract infection: definitions, incidence, and investigations
Definitions
Urinary tract infection (UTI) is currently defined as the inflammatory response of the urothelium to bacterial invasion. UTI due to other organisms is less common and addressed elsewhere.
This inflammatory response causes a constellation of clinical symptom. In bladder infection this is described as cystitis—frequent small-volume voids, urgency, suprapubic pain or discomfort, and urethral burning on voiding (dysuria).
In acute kidney infection (acute pyelonephritis) the symptoms are fever, chills, malaise, and flank pain, often with associated LUTS of frequency, urgency, and urethral pain on voiding.
Bacteriuria is the presence of bacteria in the urine and may be asymptomatic or symptomatic and varies by age and sex (Table 5.1). Bacteriuria without pyuria indicates the presence of bacterial colonization of the urine, rather than the presence of active infection, where “active” implies an inflammatory response to bacterial invasion of the urothelium.
Risk factors for bacteriuria include female sex; increasing age; low estrogen states (menopause); pregnancy; diabetes mellitus; previous UTI; institutionalized elderly; indwelling catheters; urolithiasis; genitourinary malformation; and voiding dysfunction (including obstruction).
Pyuria is the presence of white blood cells (WBCs) in the urine in dipstick or 10 WBC/HPF (400x) in resuspended sediment of centrifuged urine. Pyuria implies an inflammatory response of the urothelium to bacterial infection or, in the absence of bacteriuria, some other pathology such as carcinoma in situ, TB infection, bladder stones, or other inflammatory conditions.
An uncomplicated UTI is one occurring in a patient with a structurally and functionally normal urinary tract. The majority of such patients are women who respond quickly to a short course of antibiotics.
A complicated UTI is one occurring in the presence of an underlying anatomical or functional abnormality (e.g., functional problems causing incomplete bladder emptying, such as bladder outlet obstruction due to BPH, DSD in spinal cord injury), urolithiasis, fistula between bladder and bowel, etc. Most UTIs in men occur in association with a structural or functional abnormality and are therefore defined as complicated UTIs.
Complicated UTIs take longer to respond to antibiotic treatment than uncomplicated UTIs, and if there is an underlying anatomical or structural abnormality they are at increased risk of recurrence within days, weeks, or months.
UTI may also be classified as isolated, recurrent, or unresolved.
Isolated UTI has an interval of at least 6 months between infections.
Recurrent UTI is >2 infections in 6 months, or 3 within 12 months. Recurrent UTI may be due to reinfection (i.e., infection by a different
URINARY TRACT INFECTION 135
Table 5.1 Prevalence of bacteriuria
Age |
Female |
Male |
Infants (<1 year) |
1% |
3% |
School (<15 years old) |
1–3% |
<1% |
Reproductive |
4% |
<1% |
Elderly |
20–30% |
10% |
|
|
|
bacteria) or bacterial persistence (infection by the same organism originating from a focus within the urinary tract).
Bacterial persistence is caused by the presence of bacteria within calculi (e.g., struvite calculi), a chronically infected prostate (chronic bacterial prostatitis), or an obstructed or atrophic infected kidney, or it occurs as a result of a bladder fistula (with bowel or vagina) or urethral diverticulum.
Unresolved infection is failure of the initial treatment course to eradicate bacteria from the urine. It is usually due to pre-existing or acquired antimicrobial resistance, patient noncompliance with therapy, insufficient antibiotic dosing, or disorders that decrease drug bioavailability (i.e., azotemia, urinary calculus)
UTI incidence
•Newborns <1 year: Male children have a slightly higher risk of UTI than females, which is thought to be caused by foreskin contamination and congenital structural abnormalities.
•Children 1–5 years: Females have approximately a 5% incidence of UTI compared to 0.5% in males, and anatomic anomalies account for the majority of UTIs in both sexes.
•Children 6–15 years: Functional voiding abnormalities account for the increased incidence of UTIs (about 5% in females) with a low rate (<0.5–1%) in males.
•Adolescents and adults 16–35 years: Females have a much higher risk of UTI related to sexual activity and the use of intravaginal contraceptives.
•Adults >35 years: The incidence of UTI gradually increases in both sexes until the incidence is similar above age 65 (40% incidence in females vs. 35% in males)
UTI investigations
Urine dipstick
Urine dipstick, obtained from a mid-stream sample, is used as a first-line screening. Urine dipstick has the following performance characteristics: leukocyte esterase, 50% positive predictive value and 92% negative predictive value; nitrate, sensitivity 35%–85%. Best performance for dipstick is when urine culture colony counts are >100,000 CFU/HPF.
However, if the dipstick is negative for blood, protein, leukocyte esterase, and nitrite, <2% of urine samples will be positive for cultured bacteria.
136 CHAPTER 5 Infections and inflammatory conditions
Leukocyte esterase
Leukocyte esterase activity detects the presence of white blood cells in the urine. Leukocyte esterase is produced by neutrophils and causes a color change in a chromogen salt on the dipstick.
•False positive (pyuria present but negative dipstick test): concentrated urine, glycosuria, presence of urobilinogen, consumption of large amounts of ascorbic acid
•False positive (pyuria absent, but positive dipstick test): contamination (vaginal, etc).
There are many causes for pyuria and a positive leukocyte esterase test occurring in the absence of bacteria on urine microscopy. This is so-called sterile pyuria and it occurs with TB infection, renal calculi, bladder calculi, glomerulonephritis, interstitial cystitis, and carcinoma in situ. Thus, the leukocyte esterase dipstick test may be truly positive and suggest a significant disease process, in the absence of infection.
Nitrites
Nitrates are not normally found in urine and are produced by the dietary breakdown of nitrates in the urine by various gram-negative bacteria. Nitrite testing is therefore indirect testing for bacteriuria but may miss gram-positive infections.
Many species of gram-negative bacteria can convert nitrates to nitrites, and these are detected in urine by a reaction with the reagents on the dipstick that form a red azo dye.
The specificity of the nitrite dipstick for detecting bacteriuria is >90% with sensitivity of 35–85% (i.e., false negatives are common—a negative dipstick in the presence of active infection) and is less accurate in urine containing fewer than 105 organisms/mL. So, if the nitrite dipstick test is positive, the patient probably has a UTI, but a negative test can occur in the presence of infection.
•False positive: with contamination (i.e., vaginal)
•False negative: common in setting of low dietary nitrate, diuretics, and with certain species of bacteria (e.g., Enterococcus, Staphylococcus, Pseudomonas)
Urine microscopy
Microscopic examination of the urine sediment is also helpful. After centrifugation of the sample, the observation of bacteria and >3 WBC/HPF is diagnostic of a urinary tract infection. Occasionally, a Gram stain of an uncentrifuged urine may demonstrate gram-positive or gram-negative bacteria.
If the urine specimen contains large numbers of squamous epithelial cells (cells derived from the foreskin, vaginal, or distal urethral epithelium), this suggests contamination of the specimen, and the presence of bacteria in this situation may indicate a false-positive result.
Urine culture and collection
Urine culture is the gold standard for the diagnosis of a bacterial UTI. Urine samples must be properly collected, the method of collection documented, and samples cultured immediately or, if this is not possible, stored in a refrigerator (not frozen) for up to 24 hours.
URINARY TRACT INFECTION 137
The diagnosis of UTI is based on symptomatology, urinalysis, and urine culture findings. The traditional strict definition of >105 bacteria/mL of urine is no longer required to make a diagnosis of UTI. Treatment is usually indicated if t102 CFU/mL in a patient with symptoms of UTI, particularly with associated pyuria.
The method of collection and sex of the patient can influence the results of the urine culture; see Table 5.2.
Further investigation
Based on the initial clinical evaluation, further diagnostic testing may be necessary to evaluate the cause of the urinary tract infection. While most cases of simple UTI do not require further investigation, complicated or recurrent UTI may require imaging (plain abdominal film, CT, ultrasound) or functional studies (uroflow, post void residual urine determination, urodynamics studies) Further workup is needed if the following occur:
•Symptoms and signs of upper tract infection (flank pain, malaise, fever) that suggest acute pyelonephritis, a pyonephrosis, or perinephric abscess
•Recurrent UTIs develop (see p. 142).
•The patient is pregnant.
•Unusual infecting organism (e.g., Proteus), suggesting the possibility of an infection stone
Table 5.2 Probability of UTI based on urine culture and collection method
Collection |
CFU |
Probability of infection (%) |
Suprapubic |
Gram negative any |
>99 |
|
Gram positive >1000 |
|
Catheterization |
>105 |
95 |
|
104–5 |
Likely |
|
103–4 |
Repeat |
|
<103 |
Unlikely |
Clean catch |
|
|
Male |
>104 |
Likely |
Female |
3 specimens: >105 |
95 |
|
2 specimens: >105 |
90 |
|
1 specimen: >105 |
80 |
|
5 x104–105 |
Repeat |
|
1–5 x104 symptomatic |
Repeat |
|
1–5 x104 nonsymptomatic |
Unlikely |
|
<104 |
Unlikely |
CFU, colony-forming unit.
Reproduced with permission from Chapter 13. Bacterial infections of the genitourinary tract. In Smith’s General Urology, 17th Edition, 2008. Emil A. Tanagho and Jack W. McAninch, Eds. New York: McGraw Hill.